ALC vs ALHC
Alcon Inc vs Alignment Healthcare, Inc. — AI-powered side-by-side comparison
VS
ALHC
Alignment Healthcare, Inc.
54
Watch
| Metric | ALC | ALHC |
| AI Score |
68
|
54
|
| Price |
$75.39
|
$13.18
|
| P/E Ratio |
45.39×
|
66.17×
|
| ROE |
4.4%
|
-0.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
12.5%
|
| Debt / Equity |
0.24×
|
1.25×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
23.3
|
| Beta |
0.703
|
1.101
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus ALHC.
ALC leads by 14 points.
ALC scores 68/100 (Buy) versus ALHC at 54/100 (Watch).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
ALHC Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 37.2% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 1.80) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 20.0% shows genuine earnings power backing the valuation — Value
- Revenue growing 37.2% YoY -- genuine top-line momentum — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- P/E of 70.2 is expensive by classic value standards — Value
- Price-to-book of 22.0x prices in significant intangible value — Value
- Debt-to-equity of 1.80 adds balance-sheet risk to the value case — Value